You can:
Name | Vasoactive intestinal polypeptide receptor 1 |
---|---|
Species | Homo sapiens (Human) |
Gene | VIPR1 |
Synonym | VPAC1 VIP-R-1 VIP and PACAP receptor 1 VIP-R1 RDC1 [ Show all ] |
Disease | Respiratory disease Chronic obstructive pulmonary disease; Pulmonary arterial hypertension |
Length | 457 |
Amino acid sequence | MRPPSPLPARWLCVLAGALAWALGPAGGQAARLQEECDYVQMIEVQHKQCLEEAQLENETIGCSKMWDNLTCWPATPRGQVVVLACPLIFKLFSSIQGRNVSRSCTDEGWTHLEPGPYPIACGLDDKAASLDEQQTMFYGSVKTGYTIGYGLSLATLLVATAILSLFRKLHCTRNYIHMHLFISFILRAAAVFIKDLALFDSGESDQCSEGSVGCKAAMVFFQYCVMANFFWLLVEGLYLYTLLAVSFFSERKYFWGYILIGWGVPSTFTMVWTIARIHFEDYGCWDTINSSLWWIIKGPILTSILVNFILFICIIRILLQKLRPPDIRKSDSSPYSRLARSTLLLIPLFGVHYIMFAFFPDNFKPEVKMVFELVVGSFQGFVVAILYCFLNGEVQAELRRKWRRWHLQGVLGWNPKYRHPSGGSNGATCSTQVSMLTRVSPGARRSSSFQAEVSLV |
UniProt | P32241 |
Protein Data Bank | N/A |
GPCR-HGmod model | P32241 |
3D structure model | This predicted structure model is from GPCR-EXP P32241. |
BioLiP | N/A |
Therapeutic Target Database | T86364 |
ChEMBL | CHEMBL5144 |
IUPHAR | 371 |
DrugBank | N/A |
Name | BRN 2263667 |
---|---|
Molecular formula | C12H14ClNO2 |
IUPAC name | (E)-3-(4-chlorophenyl)-N-(2-hydroxypropyl)prop-2-enamide |
Molecular weight | 239.699 |
Hydrogen bond acceptor | 2 |
Hydrogen bond donor | 2 |
XlogP | 2.0 |
Synonyms | (E)-3-(4-chlorophenyl)-N-(2-hydroxypropyl)prop-2-enamide 30687-24-2 J3.621.486D AKOS009144587 2-Propenamide, 3-(4-chlorophenyl)-N-(2-hydroxypropyl)- [ Show all ] |
Inchi Key | SVLVGTSFQFZIBO-QPJJXVBHSA-N |
Inchi ID | InChI=1S/C12H14ClNO2/c1-9(15)8-14-12(16)7-4-10-2-5-11(13)6-3-10/h2-7,9,15H,8H2,1H3,(H,14,16)/b7-4+ |
PubChem CID | 6434091 |
ChEMBL | CHEMBL3883564 |
IUPHAR | N/A |
BindingDB | N/A |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
Inhibition | -0.4 % | PMID27876250 | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417